Virginia Cancer Institute VCI (3) is a clinical research site located in Richmond, Virginia, United States 23230.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
Virginia Cancer Institute VCI (3) has participated in 1 clinical trials.
Therapeutic areas: Breast Cancer.
Sponsors: Novartis Pharmaceuticals.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Virginia Cancer Institute VCI (3) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Virginia Cancer Institute VCI (3) has 1 clinical trials on record. Their work covers Breast Cancer.
Virginia Cancer Institute VCI (3) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.